Ra Pharma® is a clinical-stage biopharmaceutical company using a proprietary peptide chemistry platform to develop novel therapeutics for the treatment of serious diseases that are caused by excessive or uncontrolled activation of the complement system, a critical component of the immune system.

NASDAQ RARX (Common Stock)
$17.09 + 0.33
Data provided by Nasdaq. Minimum 15 minutes delayed.
Stock chart for: RARX.O.  Currently trading at $17.09 with a 52 week high of $19.43 and a 52 week low of $4.78.

Recent News

Ra Pharma Announces Positive Results from Phase 1b Pharmacokinetic Study of Zilucoplan (RA101495 SC) in Patients with Renal Impairment

Read More

View All News

Upcoming Event

There are currently no events scheduled.View All Events

Contact Us

Ra Pharmaceuticals, Inc.
87 Cambridge Park Drive
Cambridge, MA 02140
Phone: (617) 401-4060
Fax: (617) 401-4061